ENTITY
Bloomage Biotechnology

Bloomage Biotechnology (963 HK)

26
Analysis
Materials • China
Bloomage Biotechnology Corporation Ltd produces hyaluronic acid used in medical, cosmetic, and food products.
more
bullish•Giant Biogene
•23 Nov 2023 16:22

2024 High Conviction - Giant Biogene - Growth Rate Keeps Moving Higher

Giant Biogene was listed in Hong Kong IPO in 2022. It has done well since and is now trading 45% above its IPO price, but its still cheap.

Logo
759 Views
Share
bearish•Mao Geping Cosmetics
•03 Dec 2025 09:55

Mao Geping IPO Lockup - US$4.7bn Lockup Release for Founders and Pre-IPO Investors

Mao Geping Cosmetics (1318 HK) raised around US$345m in its Hong Kong IPO. The lockup on its founders and pre-IPO investors is set to expire soon.

Logo
443 Views
Share
bullish•Giant Biogene
•16 May 2024 18:55

Giant Biogene Placement - Has Been Doing Well but Doesn’t Need the Cash

Giant Biogene (2367 HK) aims to raise up to US$205m via a top-up placement. In this note, we talk about the deal dynamics and run the deal through...

Logo
524 Views
Share
bearish•Giant Biogene
•02 May 2023 09:57

Giant Biogene IPO Lock-Up - US$1.7bn Lockup Release Will Increase Free Float by 14x

Giant Biogene raised around US$70m in its Hong Kong IPO, after having downsized the deal and priced it at the low-end. Its six-month lockup will...

Logo
585 Views
Share
bearish•Mao Geping Cosmetics
•05 Jun 2025 09:48

Mao Geping IPO Lockup - Stock Is up 4x, US$400m Cornerstone Lockup Release

Mao Geping Cosmetics raised around US$345m in its Hong Kong IPO. The lockup on its cornerstone investors is set to expire soon.

Logo
449 Views
Share
x